Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 2
2018 4
2019 2
2020 5
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Intraoperative prophylactic intravesical chemotherapy to reduce bladder recurrence following radical nephroureterectomy.
Freifeld Y, Ghandour R, Singla N, Woldu S, Bagrodia A, Lotan Y, Rapoport LM, Gazimiev M, Delafuente K, Kulangara R, Robyak H, Petros FG, Raman JD, Matin SF, Margulis V. Freifeld Y, et al. Among authors: robyak h. Urol Oncol. 2020 Sep;38(9):737.e11-737.e16. doi: 10.1016/j.urolonc.2020.05.002. Epub 2020 Jul 5. Urol Oncol. 2020. PMID: 32641241
Interethnic differences in the impact of body mass index on upper tract urothelial carcinoma following radical nephroureterectomy.
Yeh HC, Li CC, Chien TM, Li CY, Cheng YC, Woldu SL, Robyak H, Huang CN, Ke HL, Li WM, Lee HY, Yeh BW, Yang SF, Tu HP, Sagalowsky AI, Raman JD, Singla N, Margulis V, Lotan Y, Hsieh JT, Wu WJ. Yeh HC, et al. Among authors: robyak h. World J Urol. 2021 Feb;39(2):491-500. doi: 10.1007/s00345-020-03204-0. Epub 2020 Apr 21. World J Urol. 2021. PMID: 32318857
Preoperative predictive model and nomogram for disease recurrence following radical nephroureterectomy for high grade upper tract urothelial carcinoma.
Freifeld Y, Ghandour R, Singla N, Woldu S, Clinton T, Kulangara R, Bagrodia A, Matin SF, Petros FG, Raman JD, Robyak H, Yan J, Zhu H, Rapoport L, Lotan Y, Margulis V. Freifeld Y, et al. Among authors: robyak h. Urol Oncol. 2019 Oct;37(10):758-764. doi: 10.1016/j.urolonc.2019.06.009. Epub 2019 Aug 2. Urol Oncol. 2019. PMID: 31378586
Pathologic stage as a surrogate for oncologic outcomes after receipt of neoadjuvant chemotherapy for high-grade upper tract urothelial carcinoma.
Singla N, Christie A, Freifeld Y, Ghandour RA, Woldu SL, Clinton TN, Petros FG, Robyak H, Yeh HC, Fang D, Enikeev D, Bagrodia A, Sagalowsky AI, Lotan Y, Raman JD, Matin SF, Margulis V. Singla N, et al. Among authors: robyak h. Urol Oncol. 2020 Dec;38(12):933.e7-933.e12. doi: 10.1016/j.urolonc.2020.04.025. Epub 2020 May 16. Urol Oncol. 2020. PMID: 32430254 Free PMC article.
11 results